OpenVSafe by OpenVAERS
Search V-safe

C5C-12453-39120

3 vaccinations 6 coded responses 23 check-ins 6 free-text entries 3 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
076 / NJ
Registered
2020-12-22
Relationship
Self
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-22
    Registered in v-safe
  2. 2020-12-22
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-22
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2020-12-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2020-12-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2020-12-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2020-12-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2020-12-29
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-06
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-01-12
    Dose 2 — Pfizer-BioNTech
  11. 2021-01-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  12. 2021-01-13
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  13. 2021-01-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-01-14
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  15. 2021-01-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Axillary lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-01-15
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  17. 2021-01-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Free text: Axillary lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-01-17
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Headache, Fatigue or tiredness
    Free text: Axillary lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-01-18
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Fatigue or tiredness
    Free text: Axillary lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-01-21
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-01-26
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-02
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-02-09
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-02-16
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-02-23
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-04-13
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-07-13
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-11-17
    Dose 3 — Pfizer-BioNTech
  29. 2022-01-12
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  30. 2022-05-18
    Survey response — 6 months, dose 3
    MedDRA: COVID-19, Pregnancy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Pregnant and I was positive for covid a few weeks ago
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-22Pfizer-BioNTech
22021-01-12Pfizer-BioNTech
32021-11-17Pfizer-BioNTech No

Call center

3 call center cases

3 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-14

Systemic reaction (other): Lymphadenopathy

2021-01-15

Systemic reaction (other): Axillary lymphadenopathy

2021-01-16

Systemic reaction (other): Axillary lymphadenopathy

2021-01-17

Systemic reaction (other): Axillary lymphadenopathy

2021-01-18

Systemic reaction (other): Axillary lymphadenopathy

Release 11 — 6 months, dose 3

2022-05-18

Symptoms: Pregnant and I was positive for covid a few weeks ago

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDPregnancy · · ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…